Matthew Harper
Doctor
Pharmacology
University of Cambridge
United States of America
Biography
Matthew read natural sciences at Cambridge and stayed to complete a PhD with Stewart Sage (Department of Physiology, Development and Neuroscience) on the regulation of calcium signalling in platelets. He moved to Alastair Poole’s group in Bristol to work on platelet granule secretion and thrombosis. He is on the Editorial Board of the Journal of Thrombosis and Haemostasis, and the Editorial Advisory Panel of the Biochemical Journal. In 2015 he was appointed to a lectureship in the Pharmacology Department. His current research focuses on the triggers of platelet death, how it is controlled, and the role that it plays in thrombosis and thrombocytopenia.
Research Interest
Thrombosis, Thrombocytopenia, Platelets, Cancer chemotherapy, Cellular signalling, Cell death, Calcium ,Apoptosis, Necrosis. Phosphatidylserine exposure
Publications
-
Harper MT, Poole AW (2012). Bcl-xL –inhibitory BH3 mimetic ABT-737 depletes platelet calcium stores. Blood, 119, 4337-4338.
-
Harper MT, Poole AW. Chloride channels are necessary for full platelet phosphatidylserine exposure and procoagulant activity. Cell Death Dis, 4, e969.
-
Harper MT, Camacho Londono JE, Quick K, Camacho Londono J, Philipp SE, Birnbaumer L, Freichel M, Poole AW (2013). Transient receptor potential channels function as a coincidence signal detector mediated phosphatidylserine exposure. Science Signalling, 6, ra50.
